Management of Prader–Willi syndrome requires therapy with growth hormone (GH) and an extremely regulated diet to prevent obesity, avoid micro- and macronutrient deficiencies, and ensure optimal growth [8]. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.